SA

Spectral AI, Inc.

MDAI·NASDAQ

$2.01

+0.75%
HealthcareMedical - Devices

Spectral AI, Inc. operates as an artificial intelligence (AI) company. The company focuses on medical diagnostics for faster and accurate treatment decisions in wound care with applications involving patients with burns and diabetic foot ulcers. Its products include DeepView, a predictive diagnostic device that offers clinicians an objective and immediate assessment of a wound's healing potential prior to treatment or other medical intervention. The company is based in Dallas, Texas.

At a Glance

Live Snapshot
Market Cap$63.97M
EPS-0.2900
P/E Ratio-6.93
Earnings Date08/11/2026

mdai

Net Debt Issuance

Last Annual Value

6.71M

3-Year CAGR

119%

5-Year CAGR

63%

10-Year CAGR

28%

SA

Spectral AI, Inc. Competitors Analysis of Net Debt Issuance

MDAI · NASDAQ
CompanyNet Debt Issuance
CAGR 3Y
CAGR 5Y
CAGR 10Y
6.71M
N/AN/AN/A 
771.25K
N/AN/AN/A
0.00
N/AN/AN/A
0.00
N/AN/AN/A
0.00
N/AN/AN/A
-208.00K
N/AN/AN/A
-96.50K
N/AN/AN/A
-100.00K
N/AN/AN/A
11.00K
N/AN/AN/A
20.54M
N/A-19.3%N/A
TELA logo
TELA Bio, Inc.
NASDAQ:TELA
14.03M
N/AN/AN/A
SA

Spectral AI, Inc. Fair Value Envelope

MDAI · NASDAQ

Our analysis suggests that MDAI has a fair value of HIDDEN per share in the Base Case projection. With shares currently trading at $2.01, this represents a potential HIDDEN relative to our calculated worth for Spectral AI, Inc..

Intrinsic Value
Current Price: $2.01